ERS International Congress, Madrid 2019

Browse by day:
Saturday, 28.09.2019
Sunday, 29.09.2019
Monday, 30.09.2019
Tuesday, 01.10.2019
Wednesday, 02.10.2019

 

View the presentations you missed during Congress!

More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

 

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.


Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?

Oral Presentation
Chairs: A. Wells (London, United Kingdom), V. Cottin (Lyon, France)
Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network
M. Kreuter (Heidelberg, Germany), F. Bonella (Essen, Germany), N. Blank (Heidelberg, Germany), E. Siegert (Berlin, Germany), J. Henes (Tübingen, Germany), M. Worm (Berlin, Germany), C. Sunderkoetter (Muenster, Germany), M. Schmalzing (Wuerzburg, Germany), A. Kreuter (Oberhausen, Germany), C. Guenther (Dresden, Germany), L. Susok (Bochum, Germany), G. Zeidler (Treuenbrietzen, Germany), I. Koetter (Hamburg, Germany), U. Mueller-Ladner (Bad Nauheim, Germany), T. Krieg (Cologne, Germany), A. Juche (Berlin, Germany), T. Schmeiser (Wuppertal, Germany), G. Riemekasten (Luebeck, Germany), E. Aberer (Graz, Austria), N. Gaebelein-Wissing (Wuppertal, Germany), J. Distler (Erlangen, Germany), M. Sárdy (Munich, Germany), C. Pfeiffer (Ulm, Germany), K. Kuhr (Cologne, Germany), H. Lorenz (Heidelberg, Germany), P. Moinzadeh (Cologne, Germany), N. Hunzelmann (Cologne, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Minor salivary gland biopsy and dry ocular tests to detect occult Sjögren Syndrome in patients with interstitial pneumonia with autoimmune features
S. Auteri (Buenos Aires, Argentina), C. Garbarino (Buenos Aires, Argentina), M. Blanco (Buenos Aires, Argentina), M. Alberti (Buenos Aires, Argentina), F. Paulin (Buenos Aires, Argentina), M. Fernandez (Buenos Aires, Argentina), G. Carballo (Buenos Aires, Argentina), M. Rayá (Buenos Aires, Argentina), G. Guman (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease
F. Gester (Liege, Belgium), M. Henket (Liege, Belgium), D. Deseny (Liege, Belgium), C. Moermans (Liege, Belgium), B. André (Liege, Belgium), M. Malaise (Liege, Belgium), R. Louis (Liege, Belgium), J. Guiot (Liege, Belgium)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Disease course and outcome of progressive interstitial lung disease in systemic sclerosis
A. Hoffmann-Vold (Oslo, Norway), Y. Allanore (Paris, France), M. Alves (Ingelheim am Rhein, Germany), N. Graf (Winterthur , Switzerland), P. Airò (Brescia, Italy), L. Ananyeva (Moscow, Russian Federation), L. Czirják (Pécs, Hungary), S. Guiducci (Florence, Italy), E. Hachulla (Lille, France), M. Li (Beijing, China), C. Mihai (Zurich, Switzerland), G. Riemekasten (Lübeck, Germany), P. Sfikakis (Athens, Greece), G. Valentini (Napoli, Italy), O. Kowal-Bielecka (Bialystok, Poland), O. Distler (Zurich, Switzerland)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS trial
T. Maher (London , United Kingdom), O. Distler (Zurich , Switzerland), A. Azuma (Tokyo , Japan), A. Fischer (Denver, Colorado, United States of America), K. Highland (Cleveland, Ohio, United States of America), M. Kuwana (Tokyo , Japan), M. Mayes (Houston, Texas, United States of America), D. Wachtlin (Ingelheim am Rhein, Germany), M. Alves (Ingelheim am Rhein , Germany), M. Gahlemann (Basel , Switzerland), S. Stowasser (Ingelheim am Rhein, Germany), G. Raghu (Seattle, United States of America)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Clinical utility of CCL15 as a prognostic biomarker for hypersensitivity pneumonitis
M. Watanabe (Kochi, Japan), Y. Horimasu (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), K. Yamaguchi (Hiroshima, Japan), S. Sakamoto (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), T. Nakashima (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), S. Ohshimo (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), N. Kohno (Hiroshima, Japan), N. Hattori (Hiroshima, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Impact of BAL lymphocytosis and honeycombing presence on corticosteroid treatment effect in Fibrotic Hypersensitivity Pneumonitis
L. De Sadeleer (Leuven, Belgium), F. Hermans (Leuven, Belgium), E. De Dycker (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), E. Verbeken (Leuven, Belgium), G. Verleden (Leuven, Belgium), S. Verleden (Leuven, Belgium), W. Wuyts (Leuven, Belgium)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation